Âé¶¹Ö±²¥ Attorneys Highlighted for Perspective on New PBM Transparency Rules
February 19, 2026
BenefitsPro
Âé¶¹Ö±²¥ & Lardner LLP partner Nick Welle, senior counsel Hannah Demsien, and associate Iris Grossman were highlighted for their perspective on recent activity to increase pharmacy benefits manager (PBM) transparency in the BenefitsPro article, “.â€�
The authors present key takeaways and a helpful PBM reform cheat sheet chart summarizing new federal PBM audit rules in a Âé¶¹Ö±²¥ Health Care Law Today blog cited by BenefitsPro.
“The Âé¶¹Ö±²¥ & Lardner analysis has revealed a conflict between the new PBM audit laws and the draft DOL regulations,” BenefitsPro writes. “Different parties could end up paying for the PBM audits.”
(Subscription required)
People
Related News
October 9, 2026
In the News
Jonathan Lasken Highlighted Across the Media for Arrival to Âé¶¹Ö±²¥
Âé¶¹Ö±²¥ & Lardner LLP partner Jonathan Lasken is highlighted across the media for his recent arrival to the firm’s Washington D.C. office.
October 7, 2026
In the News
William Holtz Examines New FDA Approach to Clinical Trial Development
Âé¶¹Ö±²¥ & Lardner LLP of counsel William Holtz is quoted in the PharmaVoice article, “5 Key Facts About the FDA Expedited IND Pilot Program,â€� examining the FDA's new pilot program and its potential to accelerate clinical research.
October 5, 2026
In the News
Louis Lehot Analyzes U.S. IPO Market Trends and Outlook
Âé¶¹Ö±²¥ & Lardner LLP partner Louis Lehot is featured in the Daily Journal‘s Capital & Counsel newsletter offering insights on the current state of the U.S. IPO market and the factors influencing companies' routes to going public.